심혈관계 관련 각종 제휴 계약 : 계약 조건 및 합의 내용
Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials
상품코드 : 233135
리서치사 : Current Partnering, a division of Wildwood Ventures Limited
발행일 : 2021년 04월
페이지 정보 : 영문 550+ Pages
US $ 3,495 ₩ 3,959,000
PDF (Single User License)
US $ 5,245 ₩ 5,941,000
PDF (Multi User License - 2 to 5 Users)
US $ 10,495 ₩ 11,888,000
PDF (Single Site License - 6+ Users)
US $ 17,495 ₩ 19,818,000
PDF (Global License)


한글목차

심혈관계(Cardiovascular) 관련 각종 제휴 계약에 대해 조사 분석하고, 최근 각종 계약 동향, 대규모 계약과 대형 의약품 사업자의 계약 개요, 계약 형태, 개발 단계, 기술 종류, 적응증 부문별 디렉토리 등의 정보를 전해드립니다.

주요 요약

제1장 서론

제2장 심혈관 관련 각종 계약 동향

제3장 주요 계약

제4장 심혈관계 바이오 의약품 계약

제5장 심혈관계 제휴 계약 디렉토리

제6장 심혈관계 계약 : 증상별

제7장 제휴 자원 센터

부록

About Wildwood Ventures

도표

KSM 12.09.27

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

영문 목차

영문목차

Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies

Global Cardiovascular Partnering 2014 to 2021 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

Trends in Cardiovascular partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Cardiovascular partnering agreement structure

Cardiovascular partnering contract documents

Top Cardiovascular deals by value

Most active Cardiovascular dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.

The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Cardiovascular dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Cardiovascular dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Cardiovascular deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Cardiovascular dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Cardiovascular deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Cardiovascular partnering deals by specific Cardiovascular target announced since 2014. The chapter is organized by specific Cardiovascular therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Cardiovascular partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Cardiovascular partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Cardiovascular technologies and products.

Report scope

Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to cardiovascular trends and structure of deals entered into by leading companies worldwide.

Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials includes:

In Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials, the available deals are listed by:

The Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 850 cardiovascular deals. Analyzing actual contract agreements allows assessment of the following:

Benefits

Global Cardiovascular Partnering 2014 to 2021 provides the reader with the following key benefits:

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Cardiovascular dealmaking

Chapter 3 -Financial deal terms for Cardiovascular partnering

Chapter 4 - Leading Cardiovascular deals and dealmakers

Chapter 5 - Cardiovascular contract document directory

Chapter 6 - Cardiovascular dealmaking by therapeutic target

Appendices

TABLE OF FIGURES

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기